Haven't had much time lately? Here's what you may have missed in the last few months
New in 2015: Hairy Cell Leukaemia, Myeloproliferative Neoplasms, Thymic Epithelial Tumours, Central Venous Access, Treatment of Dyspnoea
26 May 2016
Nonadherence to endocrine therapy significantly reduces disease-free survival in postmenopausal breast cancer patients
25 May 2016
Glioblastoma patients aged over 65 years may benefit from a combined treatment approach
25 May 2016
New module by Michail Ignatiadis now available. View the presentation and take the CME test today.
24 May 2016
EGFR protein expression in stage IV squamous non-small-cell lung cancer linked to adjuvant necitumumab benefit
23 May 2016
J-P. Machiels underlines importance of EGFR target in head and neck cancer, because monoclonal antibodies against the EGFR improve outcome.
J-P Machiels underlines the importance of the EGFR target in head & neck cancer, as monoclonal antibodies against the EGFR target improve outcome. However, a limitation with anti-EGFR therapy exists, as a minority of patients will have objective response and the issue in head & neck cancer, compared to other cancers, is that there are no predictive biomarkers. He goes on to discuss the differences, at the molecular level, between HPV-positive and negative disease.